{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:45:42Z","timestamp":1775267142436,"version":"3.50.1"},"reference-count":49,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej25-0007","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T18:07:13Z","timestamp":1749838033000},"page":"1031-1039","source":"Crossref","is-referenced-by-count":1,"title":["A 10-year observational study of the effects of serum 25OH vitamin D levels on the onset of prediabetes at a preventive medicine research center"],"prefix":"10.1507","volume":"72","author":[{"given":"Kaoru","family":"Ogawa","sequence":"first","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-1434","authenticated-orcid":false,"given":"Jun","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riri","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Ito","sequence":"additional","affiliation":[{"name":"Preventive Medicine Research Center, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Endo","sequence":"additional","affiliation":[{"name":"Preventive Medicine Research Center, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Shimura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoe","family":"Kiuchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouji","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3790-6226","authenticated-orcid":false,"given":"Naotake","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Preventive Medicine Research Center, Asahi General Hospital, Chiba 289-2511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Yoshimoto M, Sakuma Y, Ogino J, Iwai R, Watanabe S, et al. (2023) Sex differences in predictive factors for onset of type 2 diabetes in Japanese individuals: a 15-year follow-up study. J Diabetes Investig 14: 37\u201347.","DOI":"10.1111\/jdi.13918"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sakuma Y, Ogino J, Iwai R, Inoue T, Takahashi H, et al. (2021) Hyperferritinemia is a predictor of onset of diabetes in Japanese males independently of decreased renal function and fatty liver: a fifteen-year follow-up study. J Clin Med Res 13: 541\u2013548.","DOI":"10.14740\/jocmr4635"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Rajalakshmi R, Uthaiah CA, Ramya CM, Madhunapantula SV, Salimath PV, et al. (2022) Comparative assessment of cognitive impairment and oxidative stress markers among vitamin D insufficient elderly patients with and without type 2 diabetes mellitus (T2DM). PLoS One 17: e0269394.","DOI":"10.1371\/journal.pone.0269394"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Huang B, Wen W, Ye S (2022) Correlation between serum 25-hydroxyvitamin D levels in albuminuria progression of diabetic kidney disease and underlying mechanisms by bioinformatics analysis. Front Endocrinol (Lausanne) 13: 880930.","DOI":"10.3389\/fendo.2022.880930"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Guo J, Mo H, Zuo L, Zhang X (2024) Association of physical activity and vitamin D deficiency with cognitive impairment in older adults: a population based cross-sectional analysis. Front Nutr 11: 1390903.","DOI":"10.3389\/fnut.2024.1390903"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Nanri A, Mizoue T, Goto A, Noda M, Sawada N, et al. (2023) Vitamin D intake and all-cause and cause-specific mortality in Japanese men and women: the Japan Public Health Center-based prospective study. Eur J Epidemiol 38: 291\u2013300.","DOI":"10.1007\/s10654-023-00968-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Mercola J, Grant WB, Wagner CL (2020) Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 12: 3361.","DOI":"10.3390\/nu12113361"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Corrao G, Cantarutti A, Monzio Compagnoni M, Franchi M, Rea F (2022) Change in healthcare during Covid-19 pandemic was assessed through observational designs. J Clin Epidemiol 142: 45\u201353.","DOI":"10.1016\/j.jclinepi.2021.10.015"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Kirii K, Mizoue T, Iso H, Takahashi Y, Kato M, et al. (2009) Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52: 2542\u20132550.","DOI":"10.1007\/s00125-009-1554-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, et al. (2019) Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 381: 520\u2013530.","DOI":"10.1056\/NEJMoa1900906"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, et al. (2023) Vitamin D and risk for type 2 diabetes in people with prediabetes : a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med 176: 355\u2013363.","DOI":"10.7326\/M22-3018"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Braun AE, Mitchel OR, Gonzalez TL, Sun T, Flowers AE, et al. (2022) Sex at the interface: the origin and impact of sex differences in the developing human placenta. Biol Sex Differ 13: 50.","DOI":"10.1186\/s13293-022-00459-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, et al. (2020) Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63: 453\u2013461.","DOI":"10.1007\/s00125-019-05040-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Hammes SR, Levin ER (2019) Impact of estrogens in males and androgens in females. J Clin Invest 129: 1818\u20131826.","DOI":"10.1172\/JCI125755"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80: 1717s\u20131720s.","DOI":"10.1093\/ajcn\/80.6.1717S"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Du T, Zhou ZG, You S, Lin J, Yang L, et al. (2009) Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 402: 133\u2013138.","DOI":"10.1016\/j.cca.2008.12.038"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Peng Z, Lu Y, Li L, Zhao Q, Feng Q, et al. (2013) The draft genome of the fast-growing non-timber forest species moso bamboo (Phyllostachys heterocycla). Nat Genet 45: 456\u2013461, 461e1\u2013461e2.","DOI":"10.1038\/ng.2569"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947\u2013953.","DOI":"10.1038\/90992"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Carvallo L, Henriquez B, Olate J, van Wijnen AJ, Lian JB, et al. (2007) The 1alpha,25-dihydroxy vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. J Steroid Biochem Mol Biol 103: 420\u2013424.","DOI":"10.1016\/j.jsbmb.2006.12.022"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, et al. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456\u2013469.","DOI":"10.1016\/j.cell.2007.05.047"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, et al. (2009) Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139: 329\u2013334.","DOI":"10.3945\/jn.108.093831"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Park S, Kim DS, Kwon DY, Yang HJ (2011) Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake. J Neuroendocrinol 23: 687\u2013698.","DOI":"10.1111\/j.1365-2826.2011.02165.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094\u20132099.","DOI":"10.2337\/diabetes.50.9.2094"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Gao Y, Wu X, Fu Q, Li Y, Yang T, et al. (2015) The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and \u03b2-cell function in newly diagnosed type 2 diabetes. J Diabetes Res 2015: 636891.","DOI":"10.1155\/2015\/636891"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Park S, Kim DS, Kang S (2016) Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-\u03b3 expression in nonobese type 2 diabetic rats. J Nutr Biochem 27: 257\u2013265.","DOI":"10.1016\/j.jnutbio.2015.09.013"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Gagnon C, Daly RM, Carpentier A, Lu ZX, Shore-Lorenti C, et al. (2014) Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and \u03b2-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One 9: e109607.","DOI":"10.1371\/journal.pone.0109607"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Sato A (2015) The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy. Hypertens Res 38: 367\u2013374.","DOI":"10.1038\/hr.2015.19"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Belenchia AM, Tosh AK, Hillman LS, Peterson CA (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97: 774\u2013781.","DOI":"10.3945\/ajcn.112.050013"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Greco EA, Lenzi A, Migliaccio S (2019) Role of hypovitaminosis D in the pathogenesis of obesity-induced insulin resistance. Nutrients 11: 1506.","DOI":"10.3390\/nu11071506"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M (2014) Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr (Rio J) 90: 28\u201334.","DOI":"10.1016\/j.jped.2013.06.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 von Hurst PR, Stonehouse W, Coad J (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient\u2014a randomised, placebo-controlled trial. Br J Nutr 103: 549\u2013555.","DOI":"10.1017\/S0007114509992017"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Nagpal J, Pande JN, Bhartia A (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26: 19\u201327.","DOI":"10.1111\/j.1464-5491.2008.02636.x"},{"key":"33","unstructured":"33 Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J (2011) Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 20: 521\u2013526."},{"key":"34","doi-asserted-by":"publisher","unstructured":"34 Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, et al. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650\u2013656.","DOI":"10.2337\/diacare.29.03.06.dc05-1961"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Pittas AG, Harris SS, Stark PC, Dawson-Hughes B (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30: 980\u2013986.","DOI":"10.2337\/dc06-1994"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, et al. (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365: 1621\u20131628.","DOI":"10.1016\/S0140-6736(05)63013-9"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Tai K, Need AG, Horowitz M, Chapman IM (2008) Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 24: 950\u2013956.","DOI":"10.1016\/j.nut.2008.04.009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Jorde R, Figenschau Y (2009) Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48: 349\u2013354.","DOI":"10.1007\/s00394-009-0020-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Li YF, Zheng X, Gao WL, Tao F, Chen Y (2022) Association between serum vitamin D levels and visceral adipose tissue among adolescents: a cross-sectional observational study in NHANES 2011\u20132015. BMC Pediatr 22: 634.","DOI":"10.1186\/s12887-022-03688-2"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40 Cominacini M, Fumaneri A, Ballerini L, Braggio M, Valenti MT, et al. (2023) Unraveling the connection: visceral adipose tissue and vitamin D levels in obesity. Nutrients 15: 4259.","DOI":"10.3390\/nu15194259"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Rush EC, Scragg R, Schaaf D, Juranovich G, Plank LD (2009) Indices of fatness and relationships with age, ethnicity and lipids in New Zealand European, M\u0101ori and Pacific children. Eur J Clin Nutr 63: 627\u2013633.","DOI":"10.1038\/ejcn.2008.15"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, et al. (2024) Vitamin D for the prevention of disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 109: 1907\u20131947.","DOI":"10.1210\/clinem\/dgae290"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Lau D (2023) In prediabetes, oral vitamin D reduces progression to new-onset diabetes. Ann Intern Med 176: Jc55.","DOI":"10.7326\/J23-0030"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44 Zhang Y, Tan H, Tang J, Li J, Chong W, et al. (2020) Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care 43: 1650\u20131658.","DOI":"10.2337\/dc19-1708"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Dawson-Hughes B, Staten MA, Knowler WC, Nelson J, Vickery EM, et al. (2020) Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the vitamin D and type 2 diabetes (D2d) study. Diabetes Care 43: 2916\u20132922.","DOI":"10.2337\/dc20-1765"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Barbarawi M, Zayed Y, Barbarawi O, Bala A, Alabdouh A, et al. (2020) Effect of vitamin D supplementation on the incidence of diabetes mellitus. J Clin Endocrinol Metab 105: dgaa335.","DOI":"10.1210\/clinem\/dgaa335"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Kawahara T, Suzuki G, Mizuno S, Inazu T, Kasagi F, et al. (2022) Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ 377: e066222.","DOI":"10.1136\/bmj-2021-066222"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, et al. (2024) Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocr Rev 45: 625\u2013654.","DOI":"10.1210\/endrev\/bnae009"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, et al. (2022) The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol 18: 96\u2013110.","DOI":"10.1038\/s41574-021-00593-z"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:33:19Z","timestamp":1757129599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0007","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ25-0007"}}